Benzinga | Aug 12, 2021 08:20AM EDT

Dare Bioscience Q2 EPS $(0.18) Misses $(0.16) Estimate

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 33.33 percent increase over losses of $(0.27) per share from the same period last year.